Zobrazeno 1 - 10 of 40 pro vyhledávání: '"Yamamoto Funazo T"'
1
Akademický článek
MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-X L expression.
Autor: Yasuda Y; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Ozasa H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. ozahiro@kuhp.kyoto-u.ac.jp., Kim YH; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yamazoe M; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Ajimizu H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yamamoto Funazo T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Nomizo T; Department of Respiratory Medicine, Takatsuki Red Cross Hospital, Takatsuki, Japan., Tsuji T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yoshida H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Sakamori Y; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Nakajima N; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Menju T; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yoshizawa A; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Date H; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Hirai T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Publikováno v: Cell death & disease [Cell Death Dis] 2020 Mar 09; Vol. 11 (3), pp. 177. Date of Electronic Publication: 2020 Mar 09.
Zobrazit plný text záznamu
2
Akademický článek
YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation.
Autor: Tsuji T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Ozasa H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. ozahiro@kuhp.kyoto-u.ac.jp., Aoki W; Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan., Aburaya S; Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan., Yamamoto Funazo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Furugaki K; Product Research Department, Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, Kanagawa, 247-8530, Japan., Yoshimura Y; Product Research Department, Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, Kanagawa, 247-8530, Japan., Yamazoe M; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Ajimizu H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Yasuda Y; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Nomizo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Sakamori Y; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Wake H; Division of System Neuroscience, Graduate School of Medicine, Kobe University, Kobe, 650-0017, Japan., Ueda M; Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan., Kim YH; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan., Hirai T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Publikováno v: Nature communications [Nat Commun] 2020 Jan 03; Vol. 11 (1), pp. 74. Date of Electronic Publication: 2020 Jan 03.
Zobrazit plný text záznamu
3
Akademický článek
Hippo Signaling at the Hallmarks of Cancer and Drug Resistance.
Autor: Kumar, Ramesh1 (AUTHOR) mcbhwj@imcb.a-star.edu.sg, Hong, Wanjin1 (AUTHOR)
Publikováno v: Cells (2073-4409). Apr2024, Vol. 13 Issue 7, p564. 13p.
Zobrazit plný text záznamu
4
Akademický článek
PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer.
Autor: Khan, Sajid1,2 (AUTHOR) khans10@uthscsa.edu, Cao, Lin1 (AUTHOR), Wiegand, Janet3 (AUTHOR), Zhang, Peiyi4 (AUTHOR), Zajac-Kaye, Maria5 (AUTHOR), Kaye, Frederic J.6 (AUTHOR), Zheng, Guangrong4 (AUTHOR), Zhou, Daohong1,2 (AUTHOR)
Publikováno v: Cells (2073-4409). Mar2024, Vol. 13 Issue 6, p528. 13p.
Zobrazit plný text záznamu
5
Akademický článek
Connecting the mechanisms of tumor sex differences with cancer therapy.
Autor: Li, Huan, Jiang, Weibo, Liu, Shui, Yang, Manshi, Chen, Siyuan, Pan, Yihan, Cui, Mengying
Publikováno v: Molecular & Cellular Biochemistry; Feb2024, Vol. 479 Issue 2, p213-231, 19p
Zobrazit plný text záznamu
6
Akademický článek
Functional apoptosis profiling identifies MCL-1 and BCL-xL as prognostic markers and therapeutic targets in advanced thymomas and thymic carcinomas.
Autor: Müller, Denise1 (AUTHOR), Mazzeo, Paolo2 (AUTHOR), Koch, Raphael2 (AUTHOR), Bösherz, Mark-Sebastian1 (AUTHOR), Welter, Stefan3 (AUTHOR), von Hammerstein-Equord, Alexander4 (AUTHOR), Hinterthaner, Marc5 (AUTHOR), Cordes, Lucia3 (AUTHOR), Belharazem, Djeda6 (AUTHOR), Marx, Alexander6 (AUTHOR), Ströbel, Philipp1 (AUTHOR) philipp.stroebel@med.uni-goettingen.de, Küffer, Stefan1 (AUTHOR)
Publikováno v: BMC Medicine. 11/16/2021, Vol. 19 Issue 1, p1-14. 14p.
Zobrazit plný text záznamu
8
Akademický článek
FBXW7 affects autophagy through MCL1 in oral squamous cell carcinoma.
Autor: Sun, Yang, Nie, Wei, Qiu, Bo, Yang, Qi, Zhao, Huanhuan
Publikováno v: Oral Diseases; Nov2023, Vol. 29 Issue 8, p3259-3267, 9p
Zobrazit plný text záznamu
9
Akademický článek
Combined blockade of GPX4 and activated EGFR/HER3 bypass pathways inhibits the development of ALK-inhibitor-induced tolerant persister cells in ALK-fusion-positive lung cancer.
Autor: Furugaki K; Product Research Department, Chugai Pharmaceutical Co., Ltd, Yokohama, Japan., Fujimura T; Product Research Department, Chugai Pharmaceutical Co., Ltd, Yokohama, Japan., Sakaguchi N; Biological Technology Department, Chugai Pharmaceutical Co., Ltd, Yokohama, Japan., Watanabe Y; Division of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan., Uchibori K; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Miyauchi E; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan., Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Sayama, Japan., Katayama R; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan., Yoshiura S; Product Research Department, Chugai Pharmaceutical Co., Ltd, Yokohama, Japan.
Publikováno v: Molecular oncology [Mol Oncol] 2024 Oct 06. Date of Electronic Publication: 2024 Oct 06.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje